Oncology News Today

13/11/2025

📰 NEWS: UHNM joins forces with local Sikh community to deliver health and wellbeing event in Stoke-on-Trent

University Hospitals of North Midlands NHS Trust (UHNM) is joining forces with local Sikh leaders to promote cancer screening and healthy lifestyles for early detection and treatment (UHNM) is joining forces with local Sikh leaders to promote cancer screening and healthy lifestyles for early detection and treatment.

A special health and wellbeing event will take place at Guru Nanak Gurdwara and Sikh Cultural Centre in Stoke-on-Trent on Friday, November 14, which will bring together the local Sikh community and healthcare partners to raise awareness of cancer prevention, promote NHS screening programmes, and support early detection to improve health outcomes.

Read more here:

University Hospitals of North Midlands NHS Trust (UHNM) is joining forces with local Sikh leaders to promote cancer screening and healthy lifestyles for early detection and treatment.

13/11/2025

📰 NEWS: East London to get dedicated breast cancer centre

East London is to get its own dedicated breast cancer centre of excellence when two hospital buildings are returned to NHS use next year.

Thousands of women will benefit from faster diagnosis, safer surgery and fairer access to advanced treatment and reconstruction in bespoke facilities at St Bartholomew’s Hospital in the City of London.

Read more here: https://oncologynewstoday.co.uk/east-london-to-get-dedicated-breast-cancer-centre/

Barts Health NHS Trust Barts Charity Nuffield Health

East London is to get its own dedicated breast cancer centre of excellence when two hospital buildings are returned to NHS use next year.

11/11/2025

📰 NEWS: Young cancer patients and parents report improvements in NHS communication and information

New findings from the 2024 Under 16 Cancer Patient Experience Survey show encouraging progress in how communication and information are provided to children receiving NHS cancer care.

But there are also areas in need of improvement – including in the diagnostic process and privacy in hospitals.

Read more here: https://oncologynewstoday.co.uk/young-cancer-patients-and-parents-report-improvements-in-nhs-communication-and-information/

NHS England Picker

New findings from the 2024 Under 16 Cancer Patient Experience Survey show encouraging progress in how communication and information are provided to children receiving NHS cancer care.

11/11/2025

📰 NEWS: Study suggests need for more age-associated flexibility in treating AML

A global study led by OSUCCC-James Cancer Hospital and Solove Research Institute sheds light on how age influences the outcomes of patients with acute myeloid leukaemia (AML).

This challenges the long-standing practice of dividing patients into younger and older groups for clinical trials and treatment decisions.

Read more here:

A global study led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) sheds light on how age influences the outcomes of patients with acute myeloid leukaemia (AML).

06/11/2025

📰 NEWS: New study uncovers potential way to prevent breast cancer in pre-menopausal women

Read more here: https://oncologynewstoday.co.uk/new-study-uncovers-potential-way-to-prevent-breast-cancer-in-pre-menopausal-women/

Breast Cancer Now Prevent Breast Cancer

A new study funded by Breast Cancer Now and supported by Prevent Breast Cancer, reveals a drug approved for use in other conditions could be repurposed to prevent breast cancer in women before the menopause.

04/11/2025

📰 NEWS: Pioneering cancer team recognised for improving cancer treatment and care across the Tees Valley

Read more here: https://oncologynewstoday.co.uk/pioneering-cancer-team-recognised-for-improving-cancer-treatment-and-care-across-the-tees-valley-2/

North Tees and Hartlepool NHS Foundation Trust

Health professionals from Teesside are celebrating after scooping a regional award for their commitment to getting patients home quicker following lung surgery.

31/10/2025

📰 NEWS: New drug shows dramatic effect in shrinking lung cancer tumours

A trial testing the drug zongertinib as a first treatment for people with advanced lung cancer who have a HER2 genetic mutation shows it can eradicate tumours in some patients while reducing their size in others.

More than 49,000 cases of lung cancer are diagnosed in the UK every year. Up to four per cent of lung cancers are driven by HER2 mutations. HER2 mutations occur in both people with lung cancer caused by smoking and in lung cancer cases where people have never smoked.

The study, which was presented the findings at the ESMO - European Society for Medical Oncology Congress in Berlin, involved patients who had not had any prior treatment for their advanced lung cancer, who then took zongertinib as a daily pill.

Read more here: https://oncologynewstoday.co.uk/new-drug-shows-dramatic-effect-in-shrinking-lung-cancer-tumours/

The Royal Marsden NHS

A new drug is having a dramatic effect on shrinking lung cancer tumours, according to new research.

31/10/2025

📰 NEWS: New report into the benefits of prehabilitation in cancer care reveals significant potential to alleviate NHS pressures and enhance cancer patient outcomes

Read more here: https://oncologynewstoday.co.uk/pioneering-cancer-team-recognised-for-improving-cancer-treatment-and-care-across-the-tees-valley/

Pictured: Lora Chio, Executive Business Unit Director, BMS UK & Ireland

27/10/2025

📰 NEWS: Patients with HR+ and HER2- node positive high-risk early experience improved long term overall survival 7 years on, following 2 years of taking a targeted drug alongside standard hormone therapy, according to new research.

The 7-year data from the international monarchE trial was simultaneously published in Annals of Oncology and presented at the European Society for Medical Oncology 2025 Congress by Professor Stephen Johnston, Head of the Breast Unit and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and Professor of Breast Cancer Medicine at The Institute of Cancer Research, London.

🔗 Read more here:

Patients with HR+ and HER2- node positive high-risk early breast cancer experience improved long term overall survival seven years on, following two years of taking a targeted drug alongside standard hormone therapy, according to new research.

22/10/2025

📰 NEWS: The lung cancer screening team at Buckland Hospital in Dover – which invited more than 30,000 people for life-saving cancer checks – has won an award for its work

East Kent Hospitals University NHS Foundation Trust

🔗Read more here:

A team who have invited more than 30,000 people for life-saving cancer checks have won an award for their work.

21/10/2025

📰 NEWS: The ultimate cause of death from cancer may not be metastatic disease but an infiltration of tumours into major blood vessels that cause blood clots and multi-organ failure, suggests a new study led by UT Southwestern Medical Center

suggests

🔗 Read more here:

20/10/2025

📰 NEWS: Lung Cancer Europe has launched the largest global survey to date on the psychological and emotional impact of lung cancer, drawing on responses from 2,204 people across 31 countries

🔗 Read more here:

Lung Cancer Europe has launched the largest global survey to date on the psychological and emotional impact of lung cancer, drawing on responses from 2,204 people across 31 countries.